eBook: What’s new in neuroscience drug discovery?
The global neuroscience market has grown significantly in the last 10 years, driven predominantly by an ageing population and increasing cases of neurodegenerative diseases like Alzheimer’s disease (AD).
The neuroscience market size was estimated at $44.65 billion in 2023 and is projected to reach $65.22 billion by 2030, growing at a CAGR of 5.6%, according to analysts Grand View Research.
Some of the most significant advances in neuroscience in 2025 have been in gene therapies. Particularly groundbreaking were the results of a global clinical trial of AMT-130, the first gene therapy to be tested in people with Huntington’s, which convincingly slowed progression of the disease.
This eBook, sponsored by Emulate, explores the latest developments in our understanding of neuroscience and the new therapies coming to market, spanning neurodegenerative diseases, genetic disorders, and psychiatry.
Download this exclusive eBook to learn more about:
- The 2025 breakthroughs advancing neuroscience drug discovery
- The importance of the gut-brain axis
- Synapse structure and function in neuroscience
- The latest clinical progress in Parkinson’s disease
